Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValereum Plc Regulatory News (VLRM.PL)

Share Price Information for Valereum Plc (VLRM.PL)

Share Price is delayed by 15 minutes
Get Live Data
2.27    -0.06 (-2.58%)
Bid:
2.24
Ask:
2.30
Spread: 0.06 (2.679%)
Market Cap: £12.31m
VLRM.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Valereum Plc Share Chart

Completion of Subscription

17 Nov 2025 07:00

RNS Number : 6946H
Valereum PLC
17 November 2025
 

17/11/25

 

Valereum Plc

("Valereum", "VLRM" or the "Company")

 

Completion of £0.6m Subscription, Director Dealings and Grant of Warrants

Valereum Plc (AQSE: VLRM) announces that the Company has successfully completed the subscription to raise £0.6m as previously announced on 10 October 2025 (the "Subscription"). The raise comprised £0.225m from its Chairman, James Bannon, £0.225m from its Group CEO, Gary Cottle, and £0.15m from an unconnected party through the issuance of 12,000,000 new Ordinary Shares of £0.001 each at a subscription price of £0.05 per share (the "Subscription Shares").

In connection with the Subscription, both James Bannon and Gary Cottle have been issued 2,500,000 warrants each at an exercise price of £0.50 per warrant and 2,500,000 warrants each at an exercise price of £1.00 per warrant. The unconnected party has been issued 1,666,667 warrants at an exercise price of £0.50 per warrant plus 1,666,667 warrants at an exercise price of £1.00 per warrant. The warrants will vest immediately and will be exercisable over a period of 5 years from the issue date.

 

Admission

 

Application will be made for the 12,000,000 Subscription Shares, which will rank pari passu with the existing Ordinary Shares in issue, to be admitted to trading on the AQSE Growth Market ("Admission"). Dealings are expected to commence on or around 19 November 2025 and the issue is subject only to Admission.

 

Total voting rights

 

Following Admission, the Company's issued share capital will comprise 243,204,304 Ordinary Shares of £0.001 each, all carrying voting rights. This figure may be used by shareholders as the denominator for the calculation to determine if they are required to notify the Company of their interest in, or a change to their interest in, the Company's securities.

As previously announced, the proceeds are intended to be used to fund the scale-up of VLRM Markets through accelerating the build of an institutional-grade regulated footprint across global jurisdictions, enhancing distribution reach through strategic partnerships and collaborations, as well as expanding the utility of GATE Token across the Valereum ecosystem.

The FCA notifications, made in accordance with the requirements of the UK Market Abuse Regulation, are appended below.

The Directors of the Company accept responsibility for the contents of this announcement.

 

For further information, please contact:

 

Valereum Plc

Karl Moss

 

Tel: +44 7938 767319  Investor Hub

Fortified Securities

Guy Wheatley

 

Tel: +44 203 4117773

AQSE Corporate Adviser

First Sentinel Corporate Finance

Brian Stockbridge 

 

 

Tel: +44 20 3855 5551

 

To read more, please visit the Company's website at www.vlrm.com 

or

To engage with Valereum directly by asking questions, watching videosummaries and seeing what other shareholders have to say, navigate to our Investor Hub here: Sign Up

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES OR CONNECTED PERSONS

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Bannon

2.

Reason for the Notification

a)

Position/status

Executive Chairman

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Valereum Plc

b)

LEI

213800EJ8BFEQQ9POX79

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification Code

GI000A2P2W41

b)

Nature of the transaction

Subscription of ordinary shares

c)

Price(s) and volume(s)

 

Price

Volume

£0.05 per Ordinary Share

4,500,000

d)

Aggregated information:

·Aggregated volume

· Price

 

Single transaction, see details in item (c) above

e)

Date of the transaction

14 November 2025

f)

Place of the Transaction

Outside a trading venue

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification Code

GI000A2P2W41

b)

Nature of the transaction

Grant of warrants over ordinary shares

c)

Price(s) and volume(s)

 

Exercise price

Volume

1. Exercise price of £0.50 per warrant

 

2. Exercise price of £1.00 per warrant

1. 2,500,000

 

 

2. 2,500,000

d)

Aggregated information:

·Aggregated volume

· Price

 

5,000,000

£0.75

e)

Date of the transaction

14 November 2025

f)

Place of the Transaction

Outside a trading venue

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Gary Cottle

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Valereum Plc

b)

LEI

213800EJ8BFEQQ9POX79

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification Code

GI000A2P2W41

b)

Nature of the transaction

Subscription of ordinary shares

c)

Price(s) and volume(s)

 

Price

Volume

£0.05 per Ordinary Share

4,500,000

d)

Aggregated information:

· Aggregated volume

· Price

 

Single transaction, see details in item (c) above

e)

Date of the transaction

14 November 2025

f)

Place of the Transaction

Outside a trading venue

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification Code

GI000A2P2W41

b)

Nature of the transaction

Grant of warrants over ordinary shares

c)

Price(s) and volume(s)

 

Exercise price

Volume

3. Exercise price of £0.50 per warrant

 

4. Exercise price of £1.00 per warrant

3. 2,500,000

 

 

4. 2,500,000

d)

Aggregated information:

·Aggregated volume

· Price

 

5,000,000

£0.75

e)

Date of the transaction

14 November 2025

f)

Place of the Transaction

Outside a trading venue

 

 

 

 

IMPORTANT NOTICES

 

The Company holds cryptocurrencies or cryptoassets in its treasury. Whilst the Board of Directors of the Company considers holding cryptocurrencies to be in the best interests of the Company, the Board remains aware that the financial regulator in the UK (the Financial Conduct Authority or FCA) considers investment in cryptocurrencies to be high risk. At the outset, it is important to note that an investment in the Company is not an investment in cryptocurrencies, either directly or by proxy and shareholders will have no direct access to the Company's holdings. However, the Board of Directors consider cryptocurrencies to be an appropriate store of value and potential growth and therefore appropriate for the Company. Accordingly, the Company is and intends to continue to be materially exposed to cryptocurrencies.

 

The Company is neither authorised nor regulated by the FCA, and the purchase of certain cryptocurrencies are generally unregulated in the UK. As with most other investments, the value of cryptocurrencies can go down as well as up, and therefore the value of the Company's cryptocurrencies holdings can fluctuate. The Company may not be able to realise its cryptocurrencies holdings for the same as it paid to acquire them or even for the value the Company currently ascribes to its cryptocurrencies positions due to market movements. Neither the Company nor investors in the Company's shares are protected by the UK's Financial Ombudsman Service or the Financial Services Compensation Scheme. 

 

Cryptocurrencies may present special risks to the Company's financial position. These risks include (but are not limited to): (i) the value of cryptocurrencies can be highly volatile, with value dropping as quickly as it can rise. Investors in cryptocurrencies must be prepared to lose all money invested in cryptocurrencies; (ii) the cryptocurrencies market is largely unregulated. There is a risk of losing money due to risks such as cyber-attacks, financial crime and counterparty failure; (iii) the Company may not be able to sell its cryptocurrencies at will. The ability to sell cryptocurrencies depends on various factors, including the supply and demand in the market at the relevant time. Operational failings such as technology outages, cyber-attacks and comingling of funds could cause unwanted delay; and (iv) cryptoassets are characterised in some quarters by high degrees of fraud, money laundering and financial crime. Prospective investors in the Company are encouraged to do their own research before investing. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXEAKFKFDASFFA
Date   Source Headline
5th Jun 20264:32 pmRNS-RValereum Vox Issue 4 Published
1st Jun 20267:00 amRNSHolding(s) in Company
22nd May 20263:00 pmRNS-RValereum Vox Issue 3 Published
15th May 20267:00 amRNSPlacing and Subscription Raising £1,050,000
11th May 20264:10 pmRNS-RValereum Vox Issue 2 Published
23rd Apr 20261:45 pmRNS-RLaunch of new blog, Valereum Vox
22nd Apr 20267:00 amRNSDefinitive Agreement with QGP
21st Apr 20267:00 amRNSSettlement Agreement with Blubird
16th Apr 20267:00 amRNSDefinitive Agreement Update
10th Apr 20262:48 pmRNSReplacement - Coupon Payment Received
10th Apr 20262:07 pmRNSCoupon Payment Received
9th Apr 202611:32 amRNSShare Options and PDMR Dealings
31st Mar 20261:46 pmRNSInvestor Meeting
31st Mar 20267:31 amRNSProposed Strategic Integration and Coupon Payment
4th Mar 20267:00 amRNSOTCQB Approval
27th Feb 202610:53 amRNSVLRM Markets Organisational Update
25th Feb 20267:00 amRNSOption Agreement to Cancel 2 Million Warrants
16th Feb 20267:00 amRNSDirectorate Changes
16th Feb 20267:00 amRNSSigning of MoU with Integra Foundation
9th Feb 20267:00 amRNSSigning of MoU with RWA.io & Defactor
6th Feb 20267:00 amRNSChanges to Board of Directors
30th Jan 20262:00 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSSigning of MoU and Exercise of Warrants
27th Jan 20263:50 pmRNSHolding(s) in Company
26th Jan 20267:00 amRNSForward Strategy Update
21st Jan 20267:00 amRNSAgreement and Lifting of Suspension
22nd Dec 20257:00 amRNSContract
22nd Dec 20257:00 amRNSContract
17th Dec 20257:00 amRNSResignation of Corporate Adviser and Suspension
4th Dec 202510:56 amRNS-ROTC Application
2nd Dec 202510:34 amRNSUpdate on Capital Raise
25th Nov 20257:00 amRNSAgreement to Raise Capital
21st Nov 20257:00 amRNSExercise of Warrants
17th Nov 20257:00 amRNSCompletion of Subscription
14th Nov 20257:00 amRNSDeployment of DigiShares’ Tokenisation Platform
27th Oct 20257:00 amRNS-RCOINGT to List on VLRM Markets
10th Oct 20257:00 amRNSSubscription to Raise £600,000
7th Oct 20257:00 amRNSVLRM Markets’ Post Launch Update
1st Oct 20259:00 amRNSOption Agreement to Cancel 2m Warrants
25th Sep 20257:00 amRNSValereum Advances GATE Token Strategy
24th Sep 20254:47 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNSInterim Results
19th Sep 20257:00 amRNS-RUpdate on Strategy Implementation
10th Sep 20257:00 amRNS-RVLRM to Co-host Exclusive Side Event at TOKEN2049
4th Sep 20257:00 amRNS-RCrypto and Multi Currency Payroll Solution
20th Aug 20251:00 pmRNS-RStrategic Collaboration with ZIGChain & DigiShares
18th Aug 20257:00 amRNS-RIndirect Investee Update
14th Aug 20257:00 amRNSResult of WRAP Retail Offer
11th Aug 20254:30 pmRNSWRAP Retail Offer for up to £100,000
11th Aug 20257:00 amRNSStrategic Investment in Metrikus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.